Skip to main content

Table 3 Recurrent mutations in BRCA1/2 detected in 398 probands with epithelial ovarian cancer

From: BRCA1 and BRCA2 mutations and clinical interpretation in 398 ovarian cancer patients: comparison with breast cancer variants in a similar population

Mutation/times detected Unrelated probands (% of the total probands)
BRCA1
 c.4964_4982del19 - p.(Ser1655Tyrfs*16)/5 5 (1.3)
 c.5266dupC - p.(Gln1756Profs*74)/3 3 (0.8)
BRCA2
 c.5351dupA - p.(Asn1784Lysfs*3)/4 4 (1.0)
Total recurrent 12 (3.1)
Total recurrent (12)/total mutated (96) = 12.5%
\